Louise is responsible for leading the Clinical Development strategy, delivering the Clinical Research programs and to define and monitor the Quality Management System (QMS).
Louise joined GMP-Orphan in December 2019, with over 20 years of Pharmaceutical industry experience in Clinical Development and Quality.
Louise has held a number of senior positions at Amgen, GW Pharma and Eli Lilly as well as more recently gaining experience in the CRO industry leading the clinical outsourcing strategy for several top pharma companies.
Louise has a strong quality background starting in auditing through to establishing quality management systems and leading inspection readiness efforts and successful international inspections. Louise has broad therapeutic experience in Biomedicines and Oncology and has also worked on rare disease products. Louise has a proven track record and hands-on operational, leadership and strategic management experience.